Therapeutic Asset Ratings

157 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Lunresertib Uterine Cancer	University Health Network, Toronto	P1	CC (43)
Re-Stimulated Tumor-Infiltrating Lymphocytes Ovarian Serous Adenocarcinoma	University Health Network, Toronto	P1	CC (43)
Re-Stimulated Tumor-Infiltrating Lymphocytes Ovarian Cancer	University Health Network, Toronto	P1	CC (43)
Tbi-1301 NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients	University Health Network, Toronto	P1	CC (43)
Tbi-1301 Synovial Sarcoma	University Health Network, Toronto	P1	CC (43)
Tbi-2001 B-Cell Non-Hodgkin Lymphoma	University Health Network, Toronto	P1	CC (43)
Tbi-2001 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	University Health Network, Toronto	P1	CC (43)
Lunresertib Ovarian Cancer	University Health Network, Toronto	P1	CC (41)
TEONANACATL Bipolar Depression	University Health Network, Toronto	P1	CC (41)
Lunresertib Metastatic Malignant Neoplasm	University Health Network, Toronto	P1	C (39)
Re-Stimulated Tumor-Infiltrating Lymphocytes Primary Peritoneal Carcinoma	University Health Network, Toronto	P1	C (39)
Tbi-1301 Urinary Bladder Carcinoma	University Health Network, Toronto	P1	C (39)
Re-Stimulated Tumor-Infiltrating Lymphocytes Fallopian Tube Cancer	University Health Network, Toronto	P1	C (37)
Tbi-1301 Esophageal Cancer	University Health Network, Toronto	P1	C (37)
Tbi-1301 Liver Cancer	University Health Network, Toronto	P1	C (37)
Tbi-1301 Lung Cancer	University Health Network, Toronto	P1	C (37)
Tbi-1301 Melanoma	University Health Network, Toronto	P1	C (37)
Lunresertib Cancer	University Health Network, Toronto	P1	C (36)
Tbi-1301 Ovarian Cancer	University Health Network, Toronto	P1	C (36)
il-12 Acute Myeloid Leukemia	University Health Network, Toronto	P1	C (34)
1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)- Cognitive Deficits	University Health Network, Toronto	N/A	D (30)
FALLYPRIDE Cognitive Deficits	University Health Network, Toronto	N/A	D (30)
FAZA Locally Advanced Pancreatic Adenocarcinoma	University Health Network, Toronto	N/A	D (30)
FAZA Pancreatic Adenocarcinoma	University Health Network, Toronto	N/A	D (30)
FAZA Malignant Pancreatic Neoplasm	University Health Network, Toronto	N/A	D (30)

Showing 126 to 150 of 157 assets

PreviousPage 6 of 7Next